Peroxiredoxin II expression and its association with oxidative stress and cell proliferation in human idiopathic pulmonary fibrosis

Journal of Histochemistry and Cytochemistry

Volumn 56, Issue 10, 2008, Pages 951-959

  Vuorinen, Kirsi ^a   Ohlmeier, Steffen ^b   Leppäranta, Outi ^a   Salmenkivi, Kaisa ^a   Myllärniemi, Marjukka ^a   Kinnula, Vuokko L ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Cell proliferation; Fibroblast foci; Lung; Nitrotyrosine; Oxidative stress; Peroxiredoxin; Platelet derived growth factor; Pulmonary fibrosis

Indexed keywords

3 NITROTYROSINE; KI 67 ANTIGEN; OXIDIZING AGENT; PEROXIREDOXIN; PEROXIREDOXIN II; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG BIOPSY; LUNG FIBROBLAST; LUNG PARENCHYMA; MALE; MASS SPECTROMETRY; MORPHOMETRICS; NITROSATIVE STRESS; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL PROLIFERATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; KI-67 ANTIGEN; LUNG; MALE; MASS SPECTROMETRY; MIDDLE AGED; OXIDATIVE STRESS; PEROXIREDOXINS; PULMONARY FIBROSIS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; TYROSINE;

EID: 52949117180     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.2008.951806     Document Type: Article

References (37)

1. American Thoracic Society/European Respiratory Society (2002) International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165:277-304
2. Bae YS, Sung JY, Kim OS, Kim YJ, Hur KC, Kazlauskas A, Rhee SG (2000) Platelet-derived growth factor-induced H(2)O(2) production requires the activation of phosphatidylinositol 3-kinase. J Biol Chem 275:10527-10531
3. Bonner JC (2004) Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev 15:255-273
4. Bonner JC (2007) Lung fibrotic responses to particle exposure. Toxicol Pathol 35:148-153
5. Bonner JC, Rice AB, Lindroos PM, O'Brien PO, Dreher KL, Rosas I, Faro-Moreno E, et al. (1998) Induction of the lung myofibroblast PDGF receptor system by urban ambient particles from Mexico City. Am J Respir Cell Mol Biol 19:672-680
6. Cantin AM, Hubbard RC, Crystal RG (1989) Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 139:370-372
7. Chevallet M, Wagner E, Luche S, Van DA, Leize-Wagner E, Rabilloud T (2003) Regeneration of peroxiredoxins during recovery after oxidative stress: only some overoxidized peroxiredoxins can be reduced during recovery after oxidative stress. J Biol Chem 278:37146-37153
8. Cho HY, Reddy SP, Yamamoto M, Kleeberger SR (2004) The transcription factor NRF2 protects against pulmonary fibrosis. FASEB J 18:1258-1260
9. Choi MH, Lee IK, Kim GW, Kim BU, Han YH, Yu DY, Parks HS, et al. (2005) Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 435:347-353
10. Davis KL, Martin E, Turko IV, Murad F (2001) Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 41:203-236
11. Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, et al. (2005) High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353:2229-2242
12. Gonzalez-Rubio M, Voit S, Rodriguez-Puyol D, Weber M, Marx M (1996) Oxidative stress induces tyrosine phosphorylation of PDGF alpha-and beta-receptors and pp60c-src in mesangial cells. Kidney Int 50:164-173
13. Hunninghake GW (2005) Antioxidant therapy for idiopathic pulmonary fibrosis. N Engl J Med 353:2285-2287
14. Kharitonov SA, Barnes PJ (2001) Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 163:1693-1722
15. Kinnula VL, Crapo JD (2004) Superoxide dismutases in malignant cells and human tumors. Free Radic Biol Med 36:718-744
16. Kinnula VL, Fattman CL, Tan RJ, Oury TD (2005) Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med 172:417-422
17. Kinnula VL, Hodgson UA, Lakari EK, Tan RJ, Sormunen RT, Soini YM, Kakko SJ, et al. (2006) Extracellular superoxide dismutase has a highly specific localization in idiopathic pulmonary fibrosis/usual interstitial pneumonia. Histopathology 49:66-74
18. Kinnula VL, Lehtonen S, Kaarteenaho-Wiik R, Lakari E, Paakko P, Kang SW, Rhee SG, et al. (2002a) Cell specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis. Thorax 57:157-164
19. Kinnula VL, Lehtonen S, Sormunen R, Kaarteenaho-Wiik R, Kang SW, Rhee SG, Soini Y (2002b) Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J Pathol 196: 316-323
20. Kinnula VL, Myllarniemi M (2008) Oxidant-antioxidant imbalance as a potential contributor to the progression of human pulmonary fibrosis. Antioxid Redox Signal 10:727-738
21. Koli K, Myllarniemi M, Keski-Oja J, Kinnula VL (2008) Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid Redox Signal 10: 333-342
22. Lakari E, Paakko P, Kinnula VL (1998) Manganese superoxide dismutase, but not CuZn superoxide dismutase, is highly expressed in the granulomas of pulmonary sarcoidosis and extrinsic allergic alveolitis. Am J Respir Crit Care Med 158:589-596
23. Lakari E, Soini Y, Saily M, Koistinen P, Paakko P, Kinnula VL (2002) Inducible nitric oxide synthase, but not xanthine oxidase, is highly expressed in interstitial pneumonias and granulomatous diseases of human lung. Am J Clin Pathol 117:132-142
24. Lasky JA, Tonthat B, Liu JY, Friedman M, Brody AR (1998) Upregulation of the PDGF-alpha receptor precedes asbestos-induced lung fibrosis in rats. Am J Respir Crit Care Med 157:1652-1657
25. Lehtonen ST, Markkanen PM, Peltoniemi M, Kang SW, Kinnula VL (2005) Variable overoxidation of peroxiredoxins in human lung cells in severe oxidative stress. Am J Physiol Lung Cell Mol Physiol 288:L997-1001
26. Lehtonen ST, Ohlmeier S, Kaarteenaho-Wiik R, Harju T, Paakko P, Soini Y, Kinnula VL (2008) Does the oxidative stress in chronic obstructive pulmonary disease cause thioredoxin/peroxiredoxin oxidation? Antioxid Redox Signal 10:813-820
27. Myllärniemi M, Vuorinen K, Pulkkinen V, Kankaanranta H, Aine T, Salmenkivi K, Keski-Oja J, et al. (2008) Gremlin localization and expression levels partially differentiate idiopathic interstitial pneumonia severity and subtype. J Pathol 214:456-463
28. Nagaoka I, Trapnell BC, Crystal RG (1990) Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis. J Clin Invest 85:2023-2027
29. Nicholson AG, Fulford LG, Colby TV, du Bois RM, Hansell DM, Wells AU (2002) The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 166:173-177
30. Peltoniemi M, Kaarteenaho-Wiik R, Saily M, Sormunen R, Paakko P, Holmgren A, Soini Y, et al. (2004) Expression of glutaredoxin is highly cell specific in human lung and is decreased by transforming growth factor-beta in vitro and in interstitial lung diseases in vivo. Hum Pathol 35:1000-1007
31. Rabilloud T, Heller M, Gasnier F, Luche S, Rey C, Aebersold R, Benahmed M, et al. (2002) Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J Biol Chem 277:19396-19401
32. Rhee SG, Chae HZ, Kim K (2005) Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 8:1543-1552
33. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T (1995) Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270:296-299
34. Tiitto L, Bloigu R, Heiskanen U, Paakko P, Kinnula VL, Kaarteenaho-Wiik R (2006) Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumonia. Thorax 61:1091-1095
35. Tiitto L, Kaarteenaho-Wiik R, Sormunen R, Holmgren A, Paakko P, Soini Y, Kinnula VL (2003) Expression of the thioredoxin system in interstitial lung disease. J Pathol 201:363-370
36. Tiitto LH, Peltoniemi MJ, Kaarteenaho-Wiik RL, Soini YM, Paakko PK, Sormunen RT, Kinnula VL (2004) Cell-specific regulation of gamma- glutamylcysteine synthetase in human interstitial lung diseases. Hum Pathol 35:832-839
37. Wagner E, Luche S, Penna L, Chevallet M, Van DA, Leize-Wagner E, Rabilloud T (2002) A method for detection of overoxidation of cysteines: peroxiredoxins are oxidized in vivo at the active-site cysteine during oxidative stress. Biochem J 366:777-785